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Abstract
Background: Leprosy typically manifests with skin and peripheral nerve involvement. Musculoskeletal complaints
are the third most common, and can be the sole presenting manifestation. They range from arthralgia/arthritis in
reactional states to full mimics of systemic rheumatic diseases. Remitting Seronegative Symmetrical Synovitis with
Pitting Oedema syndrome has only been described once in a patient with already diagnosed Leprosy.
Case report: A 68-year-old male, from an endemic region of familial amyloid polyneuropathy, presented with an
inaugural Remitting Seronegative Symmetrical Synovitis with Pitting Oedema like syndrome, more that 20 years after
travelling to Leprosy endemic areas. Arthritis would resurface whenever oral prednisone was tapered, so methotrexate
was started, controlling the complaints. Only one year later, after the appearance of peripheral neuropathy and skin
lesions, it was possible to diagnose Leprosy, through the identification of Mycobacterium leprae bacilli in a peripheral
nerve biopsy.
Conclusion: This report is an example of the heterogeneity of manifestations of Leprosy, namely rheumatic, and the
challenge of diagnosing it when typical complaints are absent. It is also a reminder that this disease should be considered
whenever a patient with a combination of skin/neurologic/rheumatic complaints has travelled to endemic countries in
the past.
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Background
Leprosy, or Hansen’s Disease, is an infectious disease
caused by Mycobacterium leprae (M. leprae) that typic-
ally affects the skin and peripheral nervous system
(PNS) [1]. Known to afflict Humanity since 600 years
BC, it is a non-cultivable, obligate intracellular, weakly
acid fast pathogen [1] [2]. Ziehl-Neelsen stains may be
negative, and Fite Faraco is the best method to identify
it; it is also the only bacterial pathogen capable of infect-
ing peripheral nerves [1]. Incubation period is long, ran-
ging from 2 to more than 20 years, with an average of 5
years [3]. Transmission, still not fully understood, ap-
pears to occur by skin-to-skin contact or nasal secre-
tions/aerosols [4].
The Ridley-Jopling classification divides Leprosy in 5
categories according to the immunological response and
number of bacilli in skin lesions, with a spectrum ran-
ging from tuberculoid to lepromatous [5]. As for the
World Health Organization (WHO), patients are classi-
fied considering the number of skin lesions and presence
of bacilli in skin smear, into paucibacillary (1 to 5 skin
lesions, bacteriological index below 2 at all sites) or mul-
tibacillary (more than 5 skin lesions; bacteriological
index of at least 2 at 1 ore more sites) [6].
Nerve involvement usually occurs early in the disease
course, most often with loss of sensory perception, but
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can also affect the motor nervous system [7]. Consider-
ing cutaneous manifestations, these range from flat,
sharply defined macules in tuberculoid lesions to diffuse
infiltration and indurated plaques and nodules in lep-
romatous lesions [1]. Despite often belittled, rheumatic
complaints can arise, and vary from feeble arthralgia/ to
pictures fully mimicking systemic rheumatic diseases [8].
Prevalence is inconstant between studies, ranging be-
tween 1 and 78% [2, 9, 10]. Pathogenesis is still not fully
understood - proposed mechanisms include reactional
states (Types I and II reaction) and direct infiltration of
the synovium [2].
The authors report the case of a patient followed at a
Rheumatology outpatient clinic for a supposed Remit-
ting Seronegative Symmetrical Synovitis with Pitting
Oedema (RS3PE) syndrome that, only after developing
polyneuropathy and skin lesions, was diagnosed with
Leprosy.
Case presentation
A 68-year-old previously healthy male presented at a
Rheumatology consultation with complaints of hand/feet
arthralgia and oedema evolving for more than 6 weeks.
He denied fever and there was no history of recent in-
fection or past similar episodes. He worked as a young
adult abroad (Iraq, Mozambique, South Africa, and
Venezuela) and was natural of an endemic area in
Portugal for familial amyloid polyneuropathy (FAP).
Examination revealed swollen and tender bilateral
metacarpophalangeal (MCPJ), proximal interphalangeal
(PIPJ), tibiotarsal and metatarsophalangeal joints, with
pitting oedema of both hands and feet.
Laboratory evaluation revealed an increase in erythro-
cyte sedimentation rate (45 mm/h) and C Reactive Pro-
tein (2.04 mg/dL), with negative rheumatoid factor and
anti-citrullinated peptide antibodies. There were no ero-
sions on hand/feet radiography. Hand ultrasound re-
vealed diffuse tenosynovitis of both extensor/flexor
compartments, besides joint effusion with doppler sign
of MCF and PIF.
Considering the global picture, the diagnosis of RS3PE
syndrome was assumed. Symptoms subsided with pred-
nisone 20 mg per day; however, peripheral arthritis re-
lapsed whenever prednisone was tapered.
At this point, an extended workup was performed to
exclude hidden neoplastic cause: trans-rectal prostate
ultrasound, cervical ultrasound, serum prostate specific
antigen, thoraco-abdomino-pelvic computed tomog-
raphy scan, colonoscopy and upper endoscopy were all
normal. The patient then started methotrexate 20 mg/
week, with remission of articular complaints and
normalization of blood inflammatory parameters.
He stayed asymptomatic for one year, when he started
progressive hypostesia/dysestesia of both hands and feet,
objectively with loss of sensitivity in glove and sock pattern.
Electromyography showed a predominantly sensitive axonal
polyneuropathy. No usual causes of polyneuropathy were
identified (diabetic, hypothyroidism, alcohol abuse, human
immunodeficiency virus, hepatitis B/C and vitamin B12/fol-
ate deficiency). Genetic study was performed, bearing in
mind the patient’s background and possibility of FAP, re-
vealing no transthyretin gene mutation.
Considering the sustained remission of articular com-
plaints, methotrexate was stopped. Neurological symp-
toms progressively worsened, culminating in the
execution of a sural nerve biopsy. Shortly after, ery-
thematous/violaceous hypoaesthetic skin papules and
plaques appeared at the trunk, face and limbs, with ex-
tensive patch lesions with hyperpigmented margins on
both legs (Fig. 1). Skin lesions’ biopsy showed numerous
epithelioid granulomas without necrosis, negative for
Mycobacterium tuberculosis complex DNA. Nerve bi-
opsy, in addition to granulomas, also showed enlarged
nerves, with lymphohistiocytic infiltrates and M. leprae
bacilli in macrophagic vacuoles through Fite Faraco
stain (Fig. 2), allowing the definitive diagnosis of multi-
bacillary Leprosy [6].
The patient started treatment with rifampicin 300mg/
month, clofazamin 300 mg/month, dapsone 100mg/day
and clofazamin 50mg/day. One year after, despite a
complete skin lesions regression, there was no improve-
ment in the peripheral neuropathy manifestations.
Discussion and conclusions
Leprosy is considered a worldwide public health prob-
lem, but non-endemic in the patient’s home country
(Portugal). According to the latest WHO reports [11],
from 2014 to 2015, the prevalence decreased from 0.32
to 0.29 per 10.000 habitants, with a new case detection
rate of 3.2 per 100.000. Fourteen countries (from Asia,
Africa and South America) declared 95% of the new
cases, with India, Brazil and Indonesia in the top 3; 768
foreign-born cases were registered, highlighting the need
to a thouroughful evaluation considering non endemic
diseases in a world where migration is on the rise.
Rheumatic manifestations of Leprosy are protean and
not fully understood. The classical musculoskeletal pic-
ture is neuropathic joint, typically in the foot and knee
[2, 12], secondary to PNS involvement. Acute, periph-
eral, remitting polyarthritis is reported in reactional
states, but chronic arthritis resembling rheumatoid arth-
ritis can also develop [8]. Sacroiliitis has also been de-
scribed [13]. Leprosy can even mimic systemic vasculitis,
for example, in the context of Lucio phenomenon or
cryoglobulinemia [12], or even Systemic Lupus Erythe-
matosus [14] and Systemic Sclerosis [15].
The case presented posed a complex diagnostic chal-
lenge. First, a presenting picture of RS3PE syndrome
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Fig. 1 Leprosy skin lesions. Legend - Erythemato-violaceous papules and plaques dispersed trough face, dorsum and tights, with large patchy
lesions with hyperpigmented margins in both lower limbs
A B
C D20 m
Fig. 2 Nerve biopsy histologic study. Legend - Nerve biopsy showing lymphohistiocytic infiltrates, which occupy almost all of the endonerve of
the various nervous fascicles observed, and with formation of multiple small non-caseous granulomas (a and b, hematoxylin and eosin). Fite
Faraco staining showed macrophage containing M.leprae bacilli (arrows; c and d)
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without skin/neurologic complaints is rarely reported in
Leprosy. In fact, only one other case labelled as RS3PE
syndrome was found in literature, but in a patient already
diagnosed with Leprosy [16]. Still, previous case series re-
port a rheumatic manifestation that could also be inter-
preted as RS3PE syndrome – “swollen hand syndrome”.
Paira et al. [17], refer to 10 patients with this term. Prasad
et al. [18], in 44 patients, describe 2 with arthritis and
swollen hand/feet and 1 with additional tenosynovitis,
however without anatomic discrimination of the arthritis
and tenosynovitis. Our case followed the typical picture of
RS3PE first described by McCarty et al. [19], with pitting
oedema and ultrasound reported tenosynovitis/arthritis of
both hands and feet in an elderly patient.
Also, despite past history of travels to endemic regions,
the incubation period in this case was very long, more
than 20 years, making virtually impossible for the clinician
that first evaluated the patient, without skin/PNS signs, to
suspect of this neglected disease. The favourable response
to corticosteroids and immunosuppression was also com-
patible with the diagnosis of a rheumatic disease. Starting
methotrexate may have allowed disease progression, with
motor-sensory neuropathy.
Here, another two factors confounded the physicians
and delayed diagnosis. First, the patient was from a FAP
endemic region. Second, leprosy typically courses with a
mononeuritic or multiple mononeuritic pattern. Poly-
neuropathy is rarer, seen in only 10.5% of the patients
with neurologic involvement [20].
Skin lesions appeared in the context of a reverse reac-
tion, early after methotrexate suspension. This could
have been the hallmark for diagnosis, as they had typical
characteristics. However, once again, the fact that Lep-
rosy is virtually inexistent in the home country delayed
correct identification, as Fite Faraco staining and bacilo-
scopy were not performed in the skin biopsy ab initio.
Fortunately, nerve histopathology results, available
shortly after, confirmed the diagnosis.
In sum, although rheumatic manifestations are com-
mon in Leprosy, diagnosing it can pose a puzzling task
when they are the sole presenting symptoms, without
skin/PNS involvement. It becomes even more challen-
ging in non-endemic countries, with misdiagnoses and
delayed treatment. The case presented is unique, com-
bining a presenting picture of RS3PE syndrome with a
subsequent chronic polyarthritis, and a place of birth
with high incidence of FAP.
Abbreviations
FAP: Familial amyloid polyneuropathy; M. leprae: Mycobacterium leprae;
MCFJ: Metacarpophalangeal joints; PIP: Proximal interphalangeal joints;
PNS: Peripheral nervous system; RS3PE: Remitting seronegative symmetrical
synovitis with pitting oedema; WHO: World Health Organization
Acknowledgements
Not applicable
Funding
No funding was received to work on or publish this case report.
Availability of data and materials
The datasets used and/or analysed during the current study are available
from the corresponding author on reasonable request.
Authors’ contributions
MG wrote the manuscript. TV, MG, HM, TS and MA were the physicians
involved in the patient’s clinical approach, including diagnosis and
treatment; RT was the neuropathologist involved in the case. All them
contributed to the writing of the manuscript, namely the case description
and discussion. RV, PP, JS and DF critically reviewed the manuscript and
contributed to the final version. All authors have read and approved the
manuscript.
Ethics approval and consent to participate
Not applicable
Consent for publication
Written consent was obtained from the patient himself. He signed a written
consent form indicating that he is aware of this case report, the pictures and
the possibility of it being published.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Rheumatology, Centro Hospitalar Vila Nova de Gaia/Espinho,
Rua Conceição Fernandes, 4434-502 Vila Nova de Gaia, Portugal.
2Department of Neurology, Centro Hospitalar Vila Nova de Gaia/Espinho, Rua
Conceição Fernandes, 4434-502 Vila Nova de Gaia, Portugal.
3Neuropathology Unit, Department of Neuroscience, Centro Hospitalar
Universitário do Porto, 4099-001 Porto, Portugal. 4Department of Infectious
Diseases, Centro Hospitalar Universitário do Porto, 4099-001 Porto, Portugal.
Received: 22 October 2018 Accepted: 15 May 2019
References
1. Scollard DM, Dacso MM, Abad-Venida ML. Tuberculosis and leprosy:
Classical Granulomatous Diseases in the Twenty-First Century. Dermatol Clin.
2015;33(3):541–62.
2. Chauhan S, Wakhlu A, Agarwal V. Arthritis in leprosy. Rheumatology
(Oxford). 2010;49(12):2237–42.
3. Schreuder PA, Noto S, Richardus JH. Epidemiologic trends of leprosy for the
21st century. Clin Dermatol. 2016;34(1):24–31.
4. Bratschi MW, Steinmann P, Wickenden A, Gillis TP. Current knowledge on
Mycobacterium leprae transmission: a systematic literature review. Lepr Rev.
2015;86(2):142–55.
5. Ridley DS, Jopling WH. Classification of leprosy according to immunity. A
five-group system. Int J Lepr Other Mycobact Dis. 1966;34(3):255–73.
6. World Health O. WHO Expert Committee on Leprosy. World Health Organ
Tech Rep Ser. 2012968):1–61, 1 p following 61.
7. Nascimento OJ. Leprosy neuropathy: clinical presentations. Arq
Neuropsiquiatr. 2013;71(9B):661–6.
8. El-Gendy H, El-Gohary RM, Shohdy KS, Ragab G. Leprosy masquerading as
systemic rheumatic diseases. J Clin Rheumatol. 2016;22(5):264–71.
9. Salvi S, Chopra A. Leprosy in a rheumatology setting: a challenging mimic
to expose. Clin Rheumatol. 2013;32(10):1557–63.
10. Alam F, Emadi SA. Case of arthritis secondary to leprosy. Springerplus. 2014;
3(734).
11. Global leprosy update. 2015: time for action, accountability and inclusion.
Wkly Epidemiol Rec. 2015;91(35):405–20.
12. Gupta L, Zanwar A, Wakhlu A, Agarwal V. Leprosy in the rheumatology
clinic: an update on this great mimic. Int J Rheum Dis. 2016;19(10):941–5.
Guerra et al. BMC Infectious Diseases          (2019) 19:455 Page 4 of 5
13. Cossermelli-Messina W, Festa Neto C, Cossermelli W. Articular inflammatory
manifestations in patients with different forms of leprosy. J Rheumatol.
1998;25(1):111–9.
14. Horta-Baas G, Hernandez-Cabrera MF, Barile-Fabris LA, Romero-Figueroa
Mdel S, Arenas-Guzman R. Multibacillary leprosy mimicking systemic lupus
erythematosus: case report and literature review. Lupus. 2015;24(10):1095–102.
15. Lee JY, Park SE, Shin SJ, Kim CW, Kim SS. Case of lepromatous leprosy
misdiagnosed as systemic sclerosis. J Dermatol. 2014;41(4):343–5.
16. Helling CA, Locursio A, Manzur ME, Sormani de Fonseca ML. Remitting
seronegative symmetrical synovitis with pitting edema in leprosy. Clin
Rheumatol. 2006;25(1):95–7.
17. Paira SO, Roverano S. The rheumatic manifestations of leprosy. Clin
Rheumatol. 1991;10(3):274–6.
18. Prasad S, Misra R, Aggarwal A, Lawrence A, Haroon N, Wakhlu A, et al.
Leprosy revealed in a rheumatology clinic: a case series. Int J Rheum Dis.
2013;16(2):129–33.
19. McCarty DJ, O'Duffy JD, Pearson L, Hunter JB. Remitting seronegative
symmetrical synovitis with pitting edema. RS3PE syndrome. JAMA. 1985;
254(19):2763–7.
20. de Freitas MR, Said G. Leprous neuropathy. Handb Clin Neurol. 2013;115:
499–514.
Guerra et al. BMC Infectious Diseases          (2019) 19:455 Page 5 of 5
